Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
RPRX
#500
Royalty Pharma plc Class A Ordinary Shares
46.210
0
+2.45%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+2.45%
Aylık değişim
+13.99%
6 aylık değişim
+24.02%
Yıllık değişim
+24.02%
Önceki kapanış
45.105
0
Open
46.210
0
Bid
Ask
Low
46.210
0
High
46.210
0
Hacim
225
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
RPRX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
444.3 M
433.32 M
421.37 M
432.29 M
427.25 M
428.42 M
—
Valuation ratios
Enterprise value
166.71 T
147.08 T
175.06 T
210.16 T
203.69 T
222.94 T
811.84 T
Price to earnings ratio
11.05
13.36
12.71
15.73
20.16
21.71
70.31
Price to sales ratio
7.46
6.7
8.12
9.09
8.6
9.17
34.98
Price to cash flow ratio
6.04
5.47
6.81
8.76
8.43
8.76
32.76
Price to book ratio
0.64
2.18
0.68
0.78
0.77
3.37
5.6
Enterprise value to EBITDA ratio
159.73 K
120.6 K
108.57 K
135.88 K
114.23 K
150.62 K
509.31 K
Profitability ratios
Return on assets %
0.03
0.01
0.01
0
0.01
0.01
0.04
Return on equity %
0.05
0.02
0.02
0
0.03
0.02
0.08
Return on invested capital %
17.7
4.88
12.36
4.81
9.4
8.33
34.9
Gross margin %
53.72
142.91
75.25
63.39
98.66
106.21
343.51
Operating margin %
130.17
36.04
94.01
36.26
70.11
62.44
262.81
EBITDA margin %
45.16
132.92
56.87
30.99
80.67
79.6
248.14
Net margin %
96.33
35.07
41.94
5.21
47.3
34.44
128.9
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
1.54
1.44
1.56
1.26
3.48
2.4
8.7
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.03
0.03
0.03
0.03
0.03
0.03
0.13
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.37
0.36
0.38
0.38
0.44
0.44
1.64
Long term debt to total equity ratio
0.96
0.95
0.99
1.1
1.34
1.32
4.75
Per share metrics
Operating cash flow per share
1.19
1.25
1.03
0.65
1.26
1.47
4.4
EBIT per share
0.42
1.32
0.55
0.31
0.87
0.87
2.59
EBITDA per share
0.43
1.33
0.56
0.32
0.88
0.88
2.63
Total debt per share
—
—
—
—
—
—
—
Cash per share
1.68
1.66
1.9
1.15
1.71
1.13
5.89
Net current asset value per share
3.03
3.03
3.19
2.7
3.31
2.71
11.9
Tangible book value per share
11.59
11.69
11.57
9.64
9.81
9.84
40.86
Working capital per share
1.06
0.92
1.14
0.56
2.36
1.58
5.64
Book value per share
11.59
11.69
11.57
11.29
11.46
11.47
45.8
Haberler
TD Cowen, Royalty Pharma için hisse hedefini büyüme ile 50 dolara yükseltti
TD Cowen raises Royalty Pharma stock price target to $50 on growth
Royalty Pharma hissesi 46,14 dolarda 52 haftalık zirve yaptı
Royalty Pharma stock hits 52-week high at 46.14 USD
Royalty Pharma Stock: 2025 Financial Performance And Strategic Outlook (NASDAQ:RPRX)
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15 - TipRanks.com
Dividend Champion, Contender, And Challenger Highlights: Week Of February 15
BofA Securities, Royalty Pharma hissesi için Al tavsiyesini 54 dolar hedefle yineliyor
Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript
Royalty Pharma hisseleri 44,94 dolar ile 52 haftalık zirveye ulaştı
Royalty Pharma stock hits 52-week high at 44.94 USD
Royalty Pharma Q4 2025 slides: double-digit growth amid synthetic royalty expansion